著者

Cheng Li-Tao Nagata Shogo Hirano Kunio Yamaguchi Shinpei Horie Shigeo Ainscough Justin Tada Takashi

出版者

Public Library of Science

雑誌

PLoS ONE (ISSN:19326203)

巻号頁・発行日

vol.7, no.2, pp.e32018, 2012-02-09

被引用文献数

10

---

マウスiPS細胞を用いた遺伝性疾患の治療モデル-多発性嚢胞腎(ADPKD)モデルマウスの治療-. 京都大学プレスリリース. 2012-2-10.

著者

Ziyi Li Xiaojie Wang Donglin Cao Ruilin Sun Cheng Li Guowei Li

出版者

International Research and Cooperation Association for Bio & Socio-Sciences Advancement

雑誌

Drug Discoveries & Therapeutics (ISSN:18817831)

巻号頁・発行日

vol.14, no.2, pp.73-76, 2020-04-30 (Released:2020-05-06)

参考文献数

14

被引用文献数

44

---

The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification.